BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 12354291)

  • 1. p-Methylthioamphetamine and 1-(m-chlorophenyl)piperazine, two non-neurotoxic 5-HT releasers in vivo, differ from neurotoxic amphetamine derivatives in their mode of action at 5-HT nerve endings in vitro.
    Gobbi M; Moia M; Pirona L; Ceglia I; Reyes-Parada M; Scorza C; Mennini T
    J Neurochem; 2002 Sep; 82(6):1435-43. PubMed ID: 12354291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 1-(m-chlorophenyl)piperazine (mCPP) dissociates in vivo serotonin release from long-term serotonin depletion in rat brain.
    Baumann MH; Ayestas MA; Dersch CM; Rothman RB
    Neuropsychopharmacology; 2001 May; 24(5):492-501. PubMed ID: 11282249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rat strain differences in the vulnerability of serotonergic nerve endings to neurotoxic damage by p-chloroamphetamine.
    Zhou D; Schreinert M; Pilz J; Huether G
    J Neural Transm (Vienna); 1996; 103(12):1381-95. PubMed ID: 9029405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo evidence for free radical involvement in the degeneration of rat brain 5-HT following administration of MDMA ('ecstasy') and p-chloroamphetamine but not the degeneration following fenfluramine.
    Colado MI; O'Shea E; Granados R; Murray TK; Green AR
    Br J Pharmacol; 1997 Jul; 121(5):889-900. PubMed ID: 9222545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-lasting behavioral sensitization to psychostimulants following p-chloroamphetamine-induced neurotoxicity in mice.
    Itzhak Y; Achat-Mendes CN; Ali SF; Anderson KL
    Neuropharmacology; 2004 Jan; 46(1):74-84. PubMed ID: 14654099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-neurotoxic amphetamine derivatives release serotonin through serotonin transporters.
    Rudnick G; Wall SC
    Mol Pharmacol; 1993 Feb; 43(2):271-6. PubMed ID: 8429828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of the translocation of protein kinase C (PKC) by 3,4-methylenedioxymethamphetamine (MDMA/ecstasy) in synaptosomes: evidence for a presynaptic localization involving the serotonin transporter (SERT).
    Kramer HK; Poblete JC; Azmitia EC
    Neuropsychopharmacology; 1998 Oct; 19(4):265-77. PubMed ID: 9718590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo analysis of serotonin clearance in rat hippocampus reveals that repeated administration of p-methoxyamphetamine (PMA), but not 3,4-methylenedioxymethamphetamine (MDMA), leads to long-lasting deficits in serotonin transporter function.
    Callaghan PD; Owens WA; Javors MA; Sanchez TA; Jones DJ; Irvine RJ; Daws LC
    J Neurochem; 2007 Feb; 100(3):617-27. PubMed ID: 17181558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N,N-dimethyl-thioamphetamine and methyl-thioamphetamine, two non-neurotoxic substrates of 5-HT transporters, have scant in vitro efficacy for the induction of transporter-mediated 5-HT release and currents.
    Gobbi M; Funicello M; Gerstbrein K; Holy M; Moya PR; Sotomayor R; Forray MI; Gysling K; Paluzzi S; Bonanno G; Reyes-Parada M; Sitte HH; Mennini T
    J Neurochem; 2008 Jun; 105(5):1770-80. PubMed ID: 18248615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serotonin transporters, serotonin release, and the mechanism of fenfluramine neurotoxicity.
    Baumann MH; Ayestas MA; Dersch CM; Partilla JS; Rothman RB
    Ann N Y Acad Sci; 2000 Sep; 914():172-86. PubMed ID: 11085319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endogenous 5-HT, released by MDMA through serotonin transporter- and secretory vesicle-dependent mechanisms, reduces hippocampal excitatory synaptic transmission by preferential activation of 5-HT1B receptors located on CA1 pyramidal neurons.
    Mlinar B; Corradetti R
    Eur J Neurosci; 2003 Sep; 18(6):1559-71. PubMed ID: 14511335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential sensitivities to the lethal, but not the neurotoxic, effects of p-chloroamphetamine in inbred rat strains.
    Fernandez F; Aguerre S; Mormède P; Chaouloff F
    Neurosci Lett; 2001 Jan; 297(1):53-7. PubMed ID: 11114483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 5-HT loss in rat brain following 3,4-methylenedioxymethamphetamine (MDMA), p-chloroamphetamine and fenfluramine administration and effects of chlormethiazole and dizocilpine.
    Colado MI; Murray TK; Green AR
    Br J Pharmacol; 1993 Mar; 108(3):583-9. PubMed ID: 7682129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p-methylthioamphetamine is a potent new non-neurotoxic serotonin-releasing agent.
    Huang X; Marona-Lewicka D; Nichols DE
    Eur J Pharmacol; 1992 Dec; 229(1):31-8. PubMed ID: 1473561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro neuronal and vascular responses to 5-hydroxytryptamine: modulation by 4-methylthioamphetamine, 4-methylthiomethamphetamine and 3,4-methylenedioxymethamphetamine.
    Murphy J; Flynn JJ; Cannon DM; Guiry PJ; McCormack P; Baird AW; McBean GJ; Keenan AK
    Eur J Pharmacol; 2002 May; 444(1-2):61-7. PubMed ID: 12191583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carrier-dependent and Ca(2+)-dependent 5-HT and dopamine release induced by (+)-amphetamine, 3,4-methylendioxymethamphetamine, p-chloroamphetamine and (+)-fenfluramine.
    Crespi D; Mennini T; Gobbi M
    Br J Pharmacol; 1997 Aug; 121(8):1735-43. PubMed ID: 9283711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of glucoprivation on serotonin neurotoxicity induced by substituted amphetamines.
    Yuan J; Cord BJ; McCann UD; Callahan BT; Ricaurte GA
    J Pharmacol Exp Ther; 2002 Nov; 303(2):831-9. PubMed ID: 12388670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short-term effects of 3,4-methylen-dioxy-metamphetamine (MDMA) on 5-HT(1A) receptors in the rat hippocampus.
    Giannaccini G; Betti L; Pirone A; Palego L; Fabiani O; Fabbrini L; Mascia G; Giusti L; Macchia M; Giusiani M; Martini C; Lucacchini A
    Neurochem Int; 2007 Dec; 51(8):496-506. PubMed ID: 17602794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypericum perforatum L. extract does not inhibit 5-HT transporter in rat brain cortex.
    Gobbi M; Valle FD; Ciapparelli C; Diomede L; Morazzoni P; Verotta L; Caccia S; Cervo L; Mennini T
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Sep; 360(3):262-9. PubMed ID: 10543427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 2-Deoxy-D-glucose prevents and nicotinamide potentiates 3, 4-methylenedioxymethamphetamine-induced serotonin neurotoxicity.
    Hervías I; Lasheras B; Aguirre N
    J Neurochem; 2000 Sep; 75(3):982-90. PubMed ID: 10936179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.